These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36740403)

  • 21. Increased serum interleukin 22 levels in patients with axial spondyloarthritis.
    Slouma M; Kharrat L; Tezegdenti A; Metoui L; Dhahri R; Ghazouani E; Cheour E; Gharsallah I; Louzir B
    Expert Rev Clin Immunol; 2023 Jan; 19(1):123-129. PubMed ID: 36326666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Response to: 'Correspondence on: irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?' by Proft
    Wallman JK; Mogard E; Marsal J; Andréasson K; Jöud A; Geijer M; Kristensen LE; Lindqvist E; Olofsson T
    Ann Rheum Dis; 2022 Jan; 81(1):e10. PubMed ID: 31892532
    [No Abstract]   [Full Text] [Related]  

  • 23. [Development of quality standards for patients with axial spondyloarthritis for use in Germany].
    Kiltz U; Buschhorn-Milberger V; Albrecht K; Lakomek HJ; Lorenz HM; Rudwaleit M; Schneider M; Schulze-Koops H; Baraliakos X; Behrens F; Brandt-Jürgens J; Haibel H; Hammel L; Karberg K; Kellner H; Krause D; Lange U; Märker-Herrmann E; Poddubnyy D; Sieper J; Syrbe U; Braun J
    Z Rheumatol; 2022 Nov; 81(9):730-743. PubMed ID: 34379181
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-radiographic axial spondyloarthritis in Tunisia: main characteristics and detailed comparison with ankylosing spondylitis.
    Ben Abdelghani K; Gzam Y; Fazaa A; Miladi S; Sellami M; Souabni L; Kassab S; Chekili S; Zakraoui L; Laater A
    Clin Rheumatol; 2021 Apr; 40(4):1361-1367. PubMed ID: 32974836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of axial spondyloarthritis: an update.
    Wang R; Ward MM
    Curr Opin Rheumatol; 2018 Mar; 30(2):137-143. PubMed ID: 29227352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibromyalgia in Axial Spondyloarthritis: A Meta-analysis.
    Son SM; Kim DS; Lee JS
    J Clin Rheumatol; 2022 Jan; 28(1):e222-e227. PubMed ID: 33298817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single center experience: physician related diagnostic delay and demographic and clinical differences between patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
    Ulutaş F; Çobankara V; Şenol H; Karasu U; Kaymaz S; Yaşar CA; Ök ZD; Yiğit M
    Rom J Intern Med; 2021 Sep; 59(3):278-285. PubMed ID: 33544548
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk factors for progression of juvenile-onset non-radiographic axial spondyloarthritis to juvenile-onset ankylosing spondylitis: a nested case-control study.
    Li HG; Wang DM; Shen FC; Huang SX; Hou ZD; Lin L; Xiao ZY
    RMD Open; 2021 Dec; 7(3):. PubMed ID: 34862311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hidden in plain sight: Is there a crucial role for enthesitis assessment in the treatment and monitoring of axial spondyloarthritis?
    McGonagle D; Aydin SZ; Marzo-Ortega H; Eder L; Ciurtin C
    Semin Arthritis Rheum; 2021 Dec; 51(6):1147-1161. PubMed ID: 34537464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Undiagnosed axSpA is prevalent in IBD.
    Onuora S
    Nat Rev Rheumatol; 2022 Nov; 18(11):612. PubMed ID: 36163435
    [No Abstract]   [Full Text] [Related]  

  • 31. Axial spondyloarthritis may protect against poor outcomes in COVID-19: propensity score matched analysis of 9766 patients from a nationwide multi-centric research network.
    Raiker R; Pakhchanian H; Kavadichanda C; Gupta L; Kardeş S; Ahmed S
    Clin Rheumatol; 2022 Mar; 41(3):721-730. PubMed ID: 34837569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sexual dimorphism in the prevalence, manifestation and outcomes of axial spondyloarthritis.
    Stovall R; van der Horst-Bruinsma IE; Liu SH; Rusman T; Gensler LS
    Nat Rev Rheumatol; 2022 Nov; 18(11):657-669. PubMed ID: 36109666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nationwide questionnaire survey on the prevalence of ankylosing spondylitis and non-radiographic axial spondyloarthritis in Japan.
    Matsubara Y; Nakamura Y; Tamura N; Kameda H; Otomo K; Kishimoto M; Kadono Y; Tsuji S; Atsumi T; Matsuno H; Takagi M; Kobayashi S; Fujio K; Nishimoto N; Okamoto N; Nakajima A; Matsui K; Yamamura M; Nakashima Y; Kawakami A; Mori M; Tomita T
    Mod Rheumatol; 2022 Aug; 32(5):960-967. PubMed ID: 34755187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of axial spondyloarthritis: an update.
    Danve A; Deodhar A
    Nat Rev Rheumatol; 2022 Apr; 18(4):205-216. PubMed ID: 35273385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Metrology in Axial Spondyloarthritis: Does It Provide Unique Information in Assessing Patients and Predicting Outcome? Results From the British Society for Rheumatology Biologic Register for Ankylosing Spondylitis.
    Biallas RL; Dean LE; Davidson L; Hollick R; Pathan E; Robertson L; Jones GT; Macfarlane GJ; Rotariu O
    Arthritis Care Res (Hoboken); 2022 Apr; 74(4):665-674. PubMed ID: 33140891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis.
    Sagard J; Olofsson T; Mogard E; Marsal J; Andréasson K; Geijer M; Kristensen LE; Lindqvist E; Wallman JK
    Arthritis Res Ther; 2022 Feb; 24(1):42. PubMed ID: 35151357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diet and Disease Activity in Patients with Axial Spondyloarthritis: SpondyloArthritis and NUTrition Study (SANUT).
    Vergne-Salle P; Salle L; Fressinaud-Marie AC; Descamps-Deplas A; Montestruc F; Bonnet C; Bertin P
    Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry.
    Bodur H; Yurdakul FG; Ataman S; Cay HF; Gurer G; Capkin E; Sezer İ; Duruoz MT; Melikoglu MA; Rezvani A; Yagci I; Gogus F; Kamanli A; Akgul O; Cevik R
    Clin Rheumatol; 2022 Jul; 41(7):2053-2063. PubMed ID: 35353263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of Fibromyalgia Syndrome and Its Relationship with Clinical Parameters in Patients with Axial Spondyloarthritis.
    Rencber N; Saglam G; Huner B; Kuru O
    Pain Physician; 2019 Nov; 22(6):E579-E585. PubMed ID: 31775411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to: 'Correspondence on 'Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort' by Micheroli
    Ciurea A; Micheroli R
    Ann Rheum Dis; 2022 Nov; 81(11):e227. PubMed ID: 32933922
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.